Xylem director granted 1,247 restricted stock units

Xylem Inc. director D Christian Koch reported an acquisition of 1,247 shares of common stock through an award of restricted stock units valued at $120.27 per share.

Rhea-AI Filing Summary

Xylem Inc. director D Christian Koch reported an acquisition of 1,247 shares of common stock through an award of restricted stock units valued at $120.27 per share. These units are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders, subject to any timely deferral election under the company’s Deferred Compensation Plan. Following this grant, Koch holds 1,247 shares directly.

Insider Trade Summary

Grant/Award: 1,247 shares

Grant/Award 1 txn

Insider KOCH D CHRISTIAN

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	1,247	$120.27	$150K

Holdings After Transaction: Common Stock — 1,247 shares (Direct)

Footnotes (1)

1. F1. Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders, unless the Reporting Person timely elects deferral in the Company's Deferred Compensation Plan.

Key Figures

Restricted stock units granted: 1,247 shares Grant reference price: $120.27 per share Shares held after transaction: 1,247 shares

3 metrics

Restricted stock units granted 1,247 shares Award of restricted stock units to director D Christian Koch

Grant reference price $120.27 per share Reported price per share for the 1,247-unit equity award

Shares held after transaction 1,247 shares Total direct holdings of D Christian Koch following the award

Key Terms

restricted stock units, Omnibus Incentive Plan, Deferred Compensation Plan

3 terms

restricted stock units financial

"Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Omnibus Incentive Plan financial

"pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated"

An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.

Deferred Compensation Plan financial

"unless the Reporting Person timely elects deferral in the Company's Deferred Compensation Plan"

A deferred compensation plan is an arrangement where an employer agrees to pay part of an employee’s pay or bonus at a later date instead of immediately, often to reduce current tax bills or to tie rewards to long-term performance. For investors it matters because these promises create future cash obligations and influence executive incentives and retention; they can affect a company’s reported liabilities, cash flow planning and the risk profile if the business faces financial trouble.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Xylem Inc. (XYL) report for D Christian Koch?

Xylem Inc. reported that director D Christian Koch received an award of 1,247 restricted stock units of common stock. The units were reported at a reference value of $120.27 per share and are held as a direct ownership position.

Was the Xylem Inc. (XYL) Form 4 transaction a purchase or an award?

The Form 4 for Xylem Inc. shows a grant/award acquisition of common stock, not an open-market purchase. Code A indicates the shares were received as a compensation-related award of restricted stock units under a company incentive plan.

How many Xylem Inc. (XYL) shares does D Christian Koch hold after this Form 4 transaction?

After the reported transaction, D Christian Koch holds 1,247 shares of Xylem Inc. common stock directly. This entire position reflects the newly awarded restricted stock units reported in the filing, with no additional holdings listed.

At what price was the Xylem Inc. (XYL) equity award to D Christian Koch valued?

The reported award for D Christian Koch was valued at $120.27 per share for 1,247 restricted stock units. This figure serves as the reference price per share associated with the compensation grant of Xylem common stock.

When do the reported Xylem Inc. (XYL) restricted stock units for D Christian Koch vest?

The 1,247 restricted stock units granted to D Christian Koch are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders, unless he elects to defer them under the company’s Deferred Compensation Plan.

Under which plan were the Xylem Inc. (XYL) restricted stock units granted to D Christian Koch?

The award to D Christian Koch was granted under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). This plan governs the restricted stock units that are scheduled to vest before the 2027 Annual Meeting of Shareholders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 04:16 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KOCH D CHRISTIAN

(Last) (First) (Middle)

C/O XYLEM INC.

301 WATER STREET SE

(Street)

WASHINGTON DISTRICT OF COLUMBIA 20003

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Xylem Inc. [ XYL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2026		A		1,247(1)	A	$120.27	1,247	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders, unless the Reporting Person timely elects deferral in the Company's Deferred Compensation Plan.

	/s/ Mike Nazario, by power of attorney for D. Christian Koch	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)